GREENOAKS CAPITAL PARTNERS LLC

Q3 2021 13F Holdings Report, Stock Holdings

Signature - Title
Patrick Lai - CFO & CCO
Location
Orinda, CA
Holdings as of
September 30, 2021
Value $
$7.45B
Num holdings
12
Date filed
11/15/2021, 04:08 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q2 2021 - Aug 16, 2021
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q3 compared to 2021 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Patrick Lai CFO & CCO San Francisco, California 11/15/2021

Note: The position in the shares of Class A Common Stock of Clover Health Investments, Corp. ("Clover") reported in this Form 13F Holdings Report and the Form 13F Holdings Reports filed by the Reporting Person for the quarters ended March 31, 2021 and June 30, 2021 were held in the form of shares of Class B Common Stock of Clover which are convertible into the shares of Class A Common Stock at the option of the holder and under certain other circumstances provided for in Clover's certificate of incorporation.